Brief: Guardion Health Sciences Announces Financial Results For The Quarter Ended March 31, 2022
May 12 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* GUARDION HEALTH SCIENCES ANNOUNCES FINANCIAL RESULTS FOR
THE
QUARTER ENDED MARCH 31, 2022
* QUARTERLY REVENUE $2.385 MILLION
* BASIC AND DILUTED NET LOSS PER SHARE FOR THREE MONTHS
ENDED
MARCH 31, 2022 WAS $0.07
Source text for Eikon: ID:nGNX6XDlx6
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview